Table 1.
Median survival time of PC14PE6/EF‐Luc and NCI‐H441/EF‐Luc orthotopic lung cancer models
| Cell type | Treatment group | No. of mice | Median survival time (days ± SD) |
|---|---|---|---|
| PC14PE6/EF‐Luc | Control (saline) | 9 | 12 ± 1.49 |
| Paclitaxel | 9 | 13 ± 1.49 | |
| NCI‐H441/EF‐Luc | Control (saline) | 13 | 12 ± 4.39 |
| Paclitaxel | 11 | 22 ± 9.34 † |
P < 0.05 versus control group.